616 related articles for article (PubMed ID: 27334138)
1. Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial.
Mazahery H; Conlon C; Beck KL; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; Mugridge O; von Hurst PR
Trials; 2016 Jun; 17(1):295. PubMed ID: 27334138
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder.
Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Jones B; von Hurst PR
J Steroid Biochem Mol Biol; 2019 Mar; 187():9-16. PubMed ID: 30744880
[TBL] [Abstract][Full Text] [Related]
3. Inflammation (IL-1β) Modifies the Effect of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids on Core Symptoms of Autism Spectrum Disorder-An Exploratory Pilot Study
Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; von Hurst PR
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121236
[TBL] [Abstract][Full Text] [Related]
4. A Randomised-Controlled Trial of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids in the Treatment of Core Symptoms of Autism Spectrum Disorder in Children.
Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; Jones B; von Hurst PR
J Autism Dev Disord; 2019 May; 49(5):1778-1794. PubMed ID: 30607782
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder.
Saad K; Abdel-Rahman AA; Elserogy YM; Al-Atram AA; El-Houfey AA; Othman HA; Bjørklund G; Jia F; Urbina MA; Abo-Elela MGM; Ahmad FA; Abd El-Baseer KA; Ahmed AE; Abdel-Salam AM
J Child Psychol Psychiatry; 2018 Jan; 59(1):20-29. PubMed ID: 27868194
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 PUFAs and vitamin D co-supplementation as a safe-effective therapeutic approach for core symptoms of autism spectrum disorder: case report and literature review.
Infante M; Sears B; Rizzo AM; Mariani Cerati D; Caprio M; Ricordi C; Fabbri A
Nutr Neurosci; 2020 Oct; 23(10):779-790. PubMed ID: 30545280
[No Abstract] [Full Text] [Related]
7. Lack of effect of vitamin D
Kerley CP; Power C; Gallagher L; Coghlan D
Arch Dis Child; 2017 Nov; 102(11):1030-1036. PubMed ID: 28626020
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.
Mazahery H; Stonehouse W; Delshad M; Kruger MC; Conlon CA; Beck KL; von Hurst PR
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218722
[TBL] [Abstract][Full Text] [Related]
9. ω-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis.
Horvath A; Łukasik J; Szajewska H
J Nutr; 2017 Mar; 147(3):367-376. PubMed ID: 28077731
[No Abstract] [Full Text] [Related]
10. ω-3 and ω-6 Fatty Acid Supplementation May Reduce Autism Symptoms Based on Parent Report in Preterm Toddlers.
Keim SA; Gracious B; Boone KM; Klebanoff MA; Rogers LK; Rausch J; Coury DL; Sheppard KW; Husk J; Rhoda DA
J Nutr; 2018 Feb; 148(2):227-235. PubMed ID: 29490101
[TBL] [Abstract][Full Text] [Related]
11. Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder.
Feng J; Shan L; Du L; Wang B; Li H; Wang W; Wang T; Dong H; Yue X; Xu Z; Staal WG; Jia F
Nutr Neurosci; 2017 Jun; 20(5):284-290. PubMed ID: 26783092
[TBL] [Abstract][Full Text] [Related]
12. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
Manson JE; Bassuk SS; Lee IM; Cook NR; Albert MA; Gordon D; Zaharris E; Macfadyen JG; Danielson E; Lin J; Zhang SM; Buring JE
Contemp Clin Trials; 2012 Jan; 33(1):159-71. PubMed ID: 21986389
[TBL] [Abstract][Full Text] [Related]
13. The Feasibility of the "Omega Kid" Study Protocol: A Double-Blind, Randomised, Placebo-Controlled Trial Investigating the Effect of Omega-3 Supplementation on Self-Regulation in Preschool-Aged Children.
Roach LA; Byrne MK; Howard SJ; Johnstone SJ; Batterham M; Wright IMR; Okely AD; de Groot RHM; van der Wurff ISM; Jones A; Meyer BJ
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33451057
[TBL] [Abstract][Full Text] [Related]
14. The effect of omega-3 long chain polyunsaturated fatty acids on aggressive behaviour in adult male prisoners: a structured study protocol for a multi-centre, double-blind, randomised placebo-controlled trial and translation into policy and practice.
Meyer BJ; Byrne MK; Cortie CH; Parletta N; Jones A; Eckermann S; Butler T; Greenberg D; Batterham M; Fernandez F; Schofield PW; Winberg PC; Bowles K; Dally J; Martin AM; Grant L
Trials; 2021 May; 22(1):318. PubMed ID: 33934704
[TBL] [Abstract][Full Text] [Related]
15. Effects of an Omega-3 and Vitamin D Supplement on Fatty Acids and Vitamin D Serum Levels in Double-Blinded, Randomized, Controlled Trials in Healthy and Crohn's Disease Populations.
Brennan Laing B; Cavadino A; Ellett S; Ferguson LR
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325778
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin D supplementation on core symptoms, serum serotonin, and interleukin-6 in children with autism spectrum disorders: A randomized clinical trial.
Javadfar Z; Abdollahzad H; Moludi J; Rezaeian S; Amirian H; Foroughi AA; Nachvak SM; Goharmehr N; Mostafai R
Nutrition; 2020; 79-80():110986. PubMed ID: 32966919
[TBL] [Abstract][Full Text] [Related]
17. Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder.
Keim SA; Jude A; Smith K; Khan AQ; Coury DL; Rausch J; Udaipuria S; Norris M; Bartram LR; Narayanan AR; Rogers LK
J Autism Dev Disord; 2022 Dec; 52(12):5342-5355. PubMed ID: 35013866
[TBL] [Abstract][Full Text] [Related]
18. Effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with colorectal cancer: a study protocol for a double blind randomized controlled trial.
Haidari F; Abiri B; Iravani M; Razavi SM; Sarbakhsh P; Ahmadi-Angali K; Vafa M
Trials; 2019 Dec; 20(1):682. PubMed ID: 31815661
[TBL] [Abstract][Full Text] [Related]
19. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
